Literature DB >> 9071938

Altered expression of mucins throughout the colon in ulcerative colitis.

J E Smithson1, A Campbell, J M Andrews, J D Milton, R Pigott, D P Jewell.   

Abstract

BACKGROUND/AIMS: Regional differences in the biology of the colonic epithelium may determine the extent of involvement by ulcerative colitis. Novel monoclonal antibodies (MAbs) were used in this study to investigate regional heterogeneity in the colonic mucosa.
METHODS: MAbs generated using a method of tolerisation against common antigens in the proximal colon and distal colon were used for immunoperoxidase staining, comparative histochemistry, immunoblotting, and slot-blot analysis.
RESULTS: The colon specific MAbs 5F1 (IgG3) and 6G4 (IgM) stained goblet cell contents throughout the normal distal colon but staining was markedly reduced in the proximal colon (p < 0.0001). In the distal colon of patients with ulcerative colitis, whether quiescent or actively inflamed, reactivity was reduced compared with controls (p < 0.05, p < 0.001 respectively). By contrast, an overall increase in staining was seen in the uninflamed proximal colon in ulcerative colitis compared with controls (p < 0.02). Comparative staining with high iron diamine and biochemical analyses indicated that MAb 6G4 was reactive with mucin bearing sulphate or O-acetylated sialic acid groups, or both.
CONCLUSIONS: Regional differences in the staining characteristics of normal colonic mucin have been shown using novel monoclonal antibodies. The pattern of mucin expression throughout the colon in ulcerative colitis is altered even in the absence of histological changes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071938      PMCID: PMC1027055          DOI: 10.1136/gut.40.2.234

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Colonic glycoproteins in monozygotic twins with inflammatory bowel disease.

Authors:  C Tysk; H Riedesel; E Lindberg; B Panzini; D Podolsky; G Järnerot
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

Review 2.  Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?

Authors:  J M Rhodes
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

3.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

4.  Expression of large intestinal mucin antigen (LIMA) epitopes in the normal and neoplastic gastrointestinal tract.

Authors:  S J Pilbrow; P J Hertzog; G D Pinczower; A W Linnane
Journal:  J Pathol       Date:  1993-03       Impact factor: 7.996

5.  Distribution of O-acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody.

Authors:  J D Milton; D Eccleston; N Parker; A Raouf; C Cubbin; J Hoffman; C A Hart; J M Rhodes
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

6.  Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis.

Authors:  A H Raouf; H H Tsai; N Parker; J Hoffman; R J Walker; J M Rhodes
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

7.  Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies.

Authors:  W D Matthew; A W Sandrock
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

8.  Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

Authors:  A Raouf; N Parker; D Iddon; S Ryder; B Langdon-Brown; J D Milton; R Walker; J M Rhodes
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Human colonic sulfomucin identified by a specific monoclonal antibody.

Authors:  T Irimura; D M Wynn; L G Hager; K R Cleary; D M Ota
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

10.  Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization.

Authors:  P I Richman; W F Bodmer
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

View more
  13 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

Review 3.  Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.

Authors:  Daniel A Peterson; Daniel N Frank; Norman R Pace; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

4.  Colonic mucus and ulcerative colitis.

Authors:  J M Rhodes
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

5.  Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa.

Authors:  Aline Dupont; Lena Heinbockel; Klaus Brandenburg; Mathias W Hornef
Journal:  Gut Microbes       Date:  2014

6.  CD4+ T cells drive goblet cell depletion during Citrobacter rodentium infection.

Authors:  Justin M Chan; Ganive Bhinder; Ho Pan Sham; Natasha Ryz; Tina Huang; Kirk S Bergstrom; Bruce A Vallance
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

7.  Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice.

Authors:  Jianxin Fu; Bo Wei; Tao Wen; Malin E V Johansson; Xiaowei Liu; Emily Bradford; Kristina A Thomsson; Samuel McGee; Lilah Mansour; Maomeng Tong; J Michael McDaniel; Thomas J Sferra; Jerrold R Turner; Hong Chen; Gunnar C Hansson; Jonathan Braun; Lijun Xia
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

Review 8.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

9.  A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

Authors:  Ian McGowan; Craig Hoesley; Ross D Cranston; Philip Andrew; Laura Janocko; James Y Dai; Alex Carballo-Dieguez; Ratiya Kunjara Na Ayudhya; Jeanna Piper; Florian Hladik; Ken Mayer
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.

Authors:  Guangyu An; Bo Wei; Baoyun Xia; J Michael McDaniel; Tongzhong Ju; Richard D Cummings; Jonathan Braun; Lijun Xia
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.